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Abstract
Background: Complementary and alternative medicine (CAM) is an increasingly common therapy
used to treat chronic pain syndromes. However; there is limited information on the utilization and
efficacy of CAM therapy in primary care patients receiving long-term opioid therapy.
Method: A survey of CAM therapy was conducted with a systematic sample of 908 primary care
patients receiving opioids as a primary treatment method for chronic pain. Subjects completed a
questionnaire designed to assess utilization, efficacy and costs of CAM therapies in this population.
Results: Patients were treated for a variety of pain problems including low back pain (38.4%),
headaches (9.9%), and knee pain (6.5%); the average duration of pain was 16 years. The median
morphine equivalent opioid dose was 41 mg/day, and the mean dose was 92 mg/day. Forty-four
percent of the sample reported CAM therapy use in the past 12 months. Therapies utilized included
massage therapy (27.3%, n = 248), chiropractic treatment (17.8%, n = 162), acupuncture (7.6%, n
= 69), yoga (6.1%, n = 55), herbs and supplements (6.8%, n = 62), and prolotherapy (5.9%, n = 54).
CAM utilization was significantly related to age female gender, pain severity income pain diagnosis
of neck and upper back pain, and illicit drug use. Medical insurance covered chiropractic treatment
(81.8%) and prolotherapy (87.7%), whereas patients primarily paid for other CAM therapies. Over
half the sample reported that one or more of the CAM therapies were helpful.
Conclusion: This study suggests CAM therapy is widely used by patients receiving opioids for
chronic pain. Whether opioids can be reduced by introducing such therapies remains to be studied.
Background
Complementary and alternative medicine (CAM) is a
treatment method frequently utilized to treat chronic pain
syndromes [1-4]. CAM can be defined both by philoso-
phy, as well as by therapeutic modality [5]. CAM practi-
tioners emphasize the holistic, individualistic,
empowering, and educational nature of CAM. Many
believe the body has the intuitive knowledge to heal itself
if given the proper tools, and encourage patients to take
responsibility for their own health. In this view, pain is
not an entity to be combated, but instead a teacher and
guide [4,5].
Examples of CAM therapy used for treating chronic pain
include acupuncture, aromatherapy, biofeedback, chiro-
practic care, energy healing, folk remedy, herbal medicine,
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homeopathy, hypnosis, imagery, lifestyle diet, massage,
megavitamins, naturopathy, osteopathy, relaxation tech-
niques, self-help groups, spiritual healing by others, cop-
per bracelets, and yoga [6,7].
The frequency of CAM therapy use for chronic pain and
other medical problems has been reported by a number of
researchers. Sherman et al. [8] conducted interviews with
249 patients with chronic low back pain and reported
54% had utilized chiropractic treatment and 38% mas-
sage therapy with massage therapy being reported as the
most helpful. Population based studies conducted by
Eisenberg et al. [6] found that from 1990 to 1997, the use
of at least one of 16 CAM therapies in the US grew from
33.8% to 42.1%. Kessler et al. [9] conducted a telephone
survey of a stratified sample of 2055 adults and reported
increasing demand for CAM therapies across all socioeco-
nomic groups. Characteristics of persons who are most
likely to use CAM therapy include adults who are between
35 and 49 years of age, non-African American, college
education, incomes above $35,000, poor health status,
and having a holistic orientation to health [2].
The efficacy of various CAM therapies for the treatment of
chronic pain remains controversial. Acupuncture is prob-
ably the most widely tested. Berman et al. [10] conducted
an acupuncture trial for the treatment of knee arthritis and
found improved function and decreased pain in the acu-
puncture group compared to sham acupuncture. A meta-
analysis conducted by Manheimer et al. [11] analyzed 33
clinical trials designed to test the efficacy of acupuncture
for the treatment of low back pain. The report found acu-
puncture significantly decreased chronic low back pain
compared to sham treatment (standard mean difference
0.54, 95%CI, 0.35–0.73). Most of these studies were lim-
ited by short follow-up, absence of controlling for poten-
tial confounding variables such as pain medication, and
small sample sizes.
Prolotherapy is an injection based CAM therapy for
chronic musculoskeletal pain in which irritant solutions
are injected at tender ligament or tendinous attachments.
A recent systematic review review of prolotherapy
reported results of 34 case series and 6 randomized con-
trolled trials for a variety of chronic pain conditions;
results were often positive but many studies had method-
ological limitations [12]. While the mechanism of healing
remain controversial, studies hypothesize that prolother-
apy may promote healing of damaged collagenous tisssue
by an anabolic inflammatory response or ablation of
pathologic nerve endings [13]. Licciardone et al. [14]
reported osteopathic manipulative treatment significantly
reduces low back pain at a level greater than expected
from placebo effects alone, persisting for at least three
months. Cherkin et al. [15] reported massage therapy was
associated with significant improvements in chronic low
back pain.
The goal of this report is to describe the utilization and
self reported efficacy of six CAM therapies (acupuncture,
chiropractic manipulation, massage therapy, yoga, prolo-
therapy and herbs/supplements) by chronic pain patients
receiving opioid therapy. In view of the potential adverse
effects of chronic opioid therapy (i.e. addiction, mood
changes, sedation, accidents, respiratory depression) CAM
therapy could provide significant pain relief and mini-
mize the use of opioids.
Methods
The primary study for which the CAM data was derived
was an interview study conducted on a systematic sample
of subjects being treated for chronic pain to assess the
point prevalence of substance use disorders and opioid
addiction. The assessment of CAM therapy utilization was
a secondary aim of the study. Additional secondary varia-
bles of interest included chronic pain diagnosis, type and
dose of opioid, opioid adverse effects, mental health dis-
orders, quality of life, costs, and current physician practice
behavior. The data presented in this paper was limited to
information relevant to CAM therapy. A number of other
papers, based on this data set, are in press with other jour-
nals. There is no significant overlap in data presented in
these papers.
Subjects were recruited with the help of 235 primary care
physicians practicing in eight counties located throughout
the state of Wisconsin. These physicians were members of
six health care systems including the University of Wis-
consin Medical Foundation, Dean Health System, Group
Health Cooperative, Medical College of Wisconsin,
Aurora Health Care, and Mercy Health Care. Interviews
were conducted in primary care clinics and research
offices in 2003 and 2004.
Primary Inclusion criteria for the primary group of interest
included: a) age between 18 and 81; b) a diagnosis of
chronic non-cancer pain; and c) current treatment with
chronic opioid therapy by a primary care physician.
Chronic pain was defined as continuous pain for at least
3 months. The average duration of pain in the sample was
16 years. Pain severity was not an inclusion criterion. The
study was approved by the Human Subjects Committees
of the University of Wisconsin, Aurora Medical Founda-
tion, Medical College of Wisconsin, Dean Care Medical
Foundation, Meriter Hospital and Mercy Health Care.
Financial support for the study was obtained from a
National Institute of Drug Abuse (NIDA) R01 grant. There
was no industry based financial support used to carry out
this study.BMC Complementary and Alternative Medicine 2007, 7:15 http://www.biomedcentral.com/1472-6882/7/15
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Subject recruitment
Physicians used a number of strategies to identify patients
being treated for chronic pain. These strategies included
obtaining patient lists from billing records using ICD-9
codes for chronic pain diagnoses, pharmacy records,
patient opioid logs maintained by individual physicians
and electronic medical record searches. The goal of the
recruitment efforts was to enroll 100% of the chronic pain
patients receiving opioid prescriptions in each of the 235
physician practices, so as to minimize selection bias. The
second step was to mail potential subjects a letter of invi-
tation from their primary care physician. Patients who did
not return an "opt-out" post card were contacted by a
study researcher by telephone, and if they met the inclu-
sion criteria, were invited to participate in a face-to-face
interview.
Written informed consent was obtained at the time of the
interview. Of the 1,252 subjects who met the initial study
criteria, 1009 participated in a face-to-face interview for a
response rate of 80% (1009/1252). Primary reasons for
non-participation included lack of time, day care issues,
confidentiality concerns and transportation barriers. For
this analysis we utilized 908 subjects out the primary sam-
ple of 1009 subjects, who reported regular opioid use in
the last 3 month and completed all elements of the CAM
survey.
Research instruments
In addition to completing a survey of CAM therapies, five
interview schedules and eight additional questionnaires
were administered. Interview and questionnaire data used
in this report included the Addiction Severity Index (ASI)
[16], the Substance Abuse Severity Scale, the chronic pain
inventory interview, the 44-question P3 scale, which
assesses emotional function [17], and the Treatment Out-
comes in Pain Survey (TOPS) which is a modified version
of the SF-36 [18]. At the end of the interview each subject
was asked to provide a urine specimen that was tested for
opioids, methadone, propoxyphene, benzodiazepines,
cocaine metabolites, amphetamines, PCP, barbiturates,
and cannabinoids.
The CAM survey focused on six CAM therapies including
acupuncture, chiropractic therapy, yoga, massage, Prolo-
therapy, and herbs, and was administered as a question-
naire. The instrument was based on surveys developed by
Eisenberg, et al. [2], Astin et al., [1], and Kessler et al. [19].
Participants were also able to write in other therapies
used. For each CAM modality patients were asked the fol-
lowing. 1) "Have you used (e.g., acupuncture) for your
pain?" (yes or no); 2) "If yes, number of times in the last
year?"; 3) "Was the therapy helpful?" (yes or no); 4) "Did
your insurance pay for some or all of this therapy?" (yes
or no); 5) "Did you have to pay for any of this therapy out
of your pocket?" (yes or no); 6) "Total you paid for ther-
apy over the last year?"
Analysis
Bivariate analysis compared demographic characteristics
of participants who reported using or not using CAM ther-
apy in the past 12 months. T-tests and chi-square tests
were performed for continuous and categorical measures
respectively. Logistic regression analysis was used to
model adjusted odds ratios of factors associated with
CAM use in the past year and to assess self-reported effi-
cacy of three types of CAM therapy. Continuous variables
incorporated into the models included age, education,
income, and SF-36 physical and mental component
scores. The analysis used increments for each of the con-
tinuous variables – age 10-year increments, education
four years, income $1000, and SF-36 10 points. The
rationale for using increments was to provide constructive
odds ratio coefficients related to the strength of the asso-
ciation. Categorical variables in the model included gen-
der, race, diagnosis, substance abuse diagnosis, and
cocaine toxicology result. Education, income, and
employment, and their corresponding categorical varia-
bles were jointly tested for inclusion in the model due to
co linearity concerns, with years of education and total
income retained. Maximum joint significance was used as
criteria for retention.
Results
Table 1 presents the characteristics of the 404 (44%) par-
ticipants who reported using a CAM therapy in the past
year, compared to 504 participants who reported never
using a CAM therapy. The majority of CAM users were
women (78.6%) with a mean age of 46.6 years. Compared
to non-CAM users, CAM users were more likely to be Cau-
casian (p < .0.01), have gone to college (54% vs. 38%, p <
0.01), be currently employed (49.9% vs. 35.7%, p < 0.01),
and have a higher monthly income ($1,636 vs. $1,322, p
< 0.01). CAM users had lower quality of life scores on the
SF-36 mental health domain scales (46.5 vs. 49.7, p <
0.05). CAM users were also more likely to have multiple
site pain, headache, or upper back and neck pain as their
primary pain complaint.
Fifty-eight percent of subjects were taking oxycodone with
22.1% receiving long acting oxycodone such as Oxycon-
tin. Other opioids utilized by the sample included hydroc-
odone (26.2%), morphine (17.2%), codeine (8.6%),
duragesic patches (8.3%), methadone (7.5%) and
hydrocodone (1.3%). Twenty-three percent of subjects
were taking more than one opioid. The mean average
daily pain rating on a scale of 1–10 was 4.8. The point
prevalence of opioid addiction, using 30 day DSM-IV cri-
teria, was 3.4% (n = 31). This compares to a point preva-
lence of 1–1.5% in general population samples or aboutBMC Complementary and Alternative Medicine 2007, 7:15 http://www.biomedcentral.com/1472-6882/7/15
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3 times above the expected frequency. Twenty-two percent
(n = 200) had a positive toxicology test for marijuana and/
or cocaine.
Table 2 reports the frequency of six types of CAM therapy
use, efficacy, and payment data. The most frequent CAM
therapy used to treat chronic pain treatment in the last
year was massage therapy (27.3%) followed by chiroprac-
tic treatment (17.8%) and acupuncture (7.6%). Yoga and
prolotherapy were used by about 6% of the subjects. The
number of times CAM therapy was utilized in the past
year varied by type of therapy, ranging from near daily use
(i.e. meditation and herbal medication) to 3.5 sessions of
prolotherapy. Insurance coverage provided part of the cost
for all types of CAM therapy with the highest reimburse-
ment rates for prolotherapy, chiropractic treatment, acu-
puncture and massage.
Table 2 also presents subjects' self perceived efficacy infor-
mation. Subjects were asked if they found their CAM ther-
Table 1: A comparison of CAM therapy users and non user (The sample consists of 908 subjects taking chronic opioids)
CAM user past 12 months No CAM Total
n = 404 n = 504 n = 908
Age-Mean 46.6** 50.0** 48.5
Gender, Female 78.6** 61.8** 69.3
Race-White or Caucasian (see footnote 1) 80.9 71.2 75.5
Black or African American 18.4 26.8 23.1
Native American 0.5 1.0 0.8
Hispanic 0.3 1.0 0.7
Education, Mean years (see footnote 2) 13.6** 12.7** 13.1
Education, 12 years or less, % 46.0 62.1 54.9
>12 and <16 years, % 29.2 23.4 26.0
16 or more years, % 24.8 14.5 19.1
Employment-Fulltime or part time 49.6* 35.7* 42.0
Student 1.0 1.0 1.0
Disability 32.3** 45.6** 39.7
Unemployed, looking for work 11.9 10.3 11.0
Marital Status-Married 44.2 41.9 42.9
Widowed 3.5 7.1 5.5
Separated or Divorced 32.0 31.4 31.6
Never Married 20.4 19.6 20.0
Opioids Utilization-Daily 86.6 89.3 88.1
10–29 days per month 13.4 10.7 11.9
Mean dose of Opioid's per day (footnote 3) 94.1 mg 90.4 mg 92 mg
Opioid addiction (DSM-IV 30 day criteria) 3.6% 3.2% 3.4%
Positive Toxicology test for illicit drugs 21.4% 24.1% 22.1%
Pain severity average daily pain (1–10 scale) 4.83 4.77 4.8
Monthly Employment Income, Mean $845** $550** $681
Total Monthly Income, Mean $1636** $1322** $1461
RAND SF-36 Physical Composite Score 33.5 32.7 33.1
RAND SF-36 Mental Composite Score 46.5* 49.7* 48.3
Primary Pain Site,
Lower back 34.9* 41.3* 38.4
Headache 12.9** 7.5** 9.9
Multiple sites 10.6** 5.9** 8.0
Knee 5.9 6.9 6.5
Neck/upper back 9.2** 5.0** 6.8
Leg 5.0 6.9 6.1
Foot and ankle 3.5* 7.1* 5.5
Shoulder 4.7 4.6 4.6
Hip 4.7 4.4 4.5
Abdominal 3.5 5.2 4.4
*p < .05, **p < .01
1. Using Chi square analysis Caucasians were more likely to use CAM therapy than African Americans. p < 0.01.
2. Using Chi square analysis subjects who utilized CAM therapy were more likely to have attended college than non CAM users. p < 0.01.
3. Opioids utilized by the chronic pain patients in the sampe (i.e. oxycodone, hydrocodone, methadone, fentanyl, meperidine, codeine) were 
converted to morphine equivalent doses using standard equivalency tables.BMC Complementary and Alternative Medicine 2007, 7:15 http://www.biomedcentral.com/1472-6882/7/15
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apy helpful. Ninety percent (220 out of 248) of persons
who received massage therapy in the last year reported the
treatment was helpful. Chiropractic treatment and yoga
were similar with 80.9% and 81.3% respectively reporting
benefit. This data suggests that when patients did utilize
CAM therapy, it was perceived to be helpful most of the
time.
Table 3 presents a logistic regression model that tested the
association of CAM therapy use in the last 12 months with
a number of factors. This table reports the adjusted odds
ratio for each variable included in the analysis. The odds
ratios in this table are adjusted for all variables listed in
table 3, using a logistic regression analysis. This analysis
allows us to simultaneously control for the variables
listed. For age we elected to use 10 years increments. As
noted in the table, the odds of using CAM interventions
compared to not using CAM methods were reduced by a
factor of 0.73 for every 10 year increment of increasing
age. This finding suggests that after adjusting for all the
factors in the model, young adults are more likely to use
CAM therapy than older adults.
The model found a statistically significant association
between CAM therapy and gender (OR 2.27: 1.64, 3.14),
age (OR 0.73: 0.63,0.85), education (OR 1.41: 1.10,1.82),
pain severity (OR 1.11: 1.01,1.22), income (OR 1.18:
1.06,1.31), neck and upper back pain location (OR 2.27:
1.24,4.14), multiple pain sites (OR 1.81: 1.05, 3.11), and
negative cocaine use (OR 1.84: 1.01, 3.36).
Discussion and conclusions
This report provides new information on CAM therapy in
a primary care sample of patients being treated with
chronic opioid therapy. The sample is unique from a
number of perspectives. First, patients in this study report
the average duration of chronic pain was 7.1 years. Sec-
ond, using a 1–10 analogue, the average daily pain sever-
ity was 4.8. Third, subjects are severely disabled, with 40%
receiving social security disability and less than 42% able
to work full- or part-time. Fourth, the majority of patients
used opioids on a daily basis at an average dose of 92 mg.
The doses ranged from 2.5 mg to 640 mg per day. Fifth,
the sample includes a wide range of chronic pain diagno-
sis. Sixth, the sample was recruited from a diverse number
of primary care practices located throughout Wisconsin
and included rural settings, a large urban area, and small
cities.
The study found that 44.2% of the sample used a CAM
therapy in the year prior to the study with massage ther-
apy and chiropractic treatment used most frequently. This
is generally consistent with use in the general US popula-
tion; Eisenberg et al. [5] reported 42.1% of the US popu-
lation had used a CAM therapy in 1997. Direct
comparison to national studies is difficult as we limited
our survey to six primary CAM therapies. The national
studies conducted by Eisenberg included 16 different
CAM therapies. We would expect higher rates in our sam-
ple if we had included all potential therapies, suggesting
patients in our sample may have higher utilization rates if
we had used a more comprehensive list. Our findings are
also similar to the prevalence of CAM use in a population
of chronic pain patients with spinal cord injuries who
reported 40.3% used these alternative treatments in the
past year [20].
Our study was consistent with other national trends.
Users of CAM therapies in this study were more likely to
be slightly younger, better educated and have slightly
Table 2: Frequency of CAM therapy use in lifetime and past year, self-reported efficacy, and cost (The sample consists of 908 subjects 
receiving chronic opioid therapy)
Lifetime use Used in the 
past year
Number of 
times used in 
the past year
Reported 
CAM therapy 
was helpful
Insurance 
coverage paid 
part of the costs
Paid some cost 
out of pocket
Mean out of 
pocket cost 
in last year
Response categories:
Acupuncture 10.1% 7.6% n = 69 10.5 59.4% 34.1% 68.1% $522
Chiropractic 23.6% 17.8% n = 162 14.1 80.9% 81.8% 46.3% $558
Yoga 7.5% 6.1% n = 55 84.0 81.8% 5.9% 55.9% $162
Massage 34.9% 27.3% n = 248 28.3 90.7% 30.8% 51.3% $486
Prolotherapy 8.3% 5.9% n = 54 3.5 68.5% 87.7% 18.8% $365
Herbs/supplements 9.4% 6.8% n = 62 202.8 77.4% 1.3% 89.1% $212
Other listed categories:
Meditation 1.7% 1.4% n = 13 264.4 84.6% 15.4% 15.4% $325
Warm water therapy 0.7% 0.7% n = 6 33.3 100.0% 83.3% 50.0% $147
Craniosacral therapy 0.4% 0.4% n = 4 10.3 75.0% 25.0% 75.0% $513
Accupressure 0.3% 0.2% n = 2 76.0 100.0% 100.0% 0.0% $0
All Others (categories 
listed by 2 or fewer 
respondents)
1.2% 1.2% n = 11 101.9 81.8% 33.3% 85.7% $913
Any CAM 64.1% 44.5% 80.1 81.6% 45.2% 54.7% $353BMC Complementary and Alternative Medicine 2007, 7:15 http://www.biomedcentral.com/1472-6882/7/15
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higher income than non-users [7]. New findings in this
report suggest CAM therapy was more frequently used by
patients with more severe pain, those with neck and upper
back pain, and persons with negative toxicology for
cocaine use.
This study raises a number of clinical and research ques-
tions that we are unable to address with the retrospective
design used for our study. What is the role of CAM therapy
in patients receiving opioids? What type of CAM therapies
should be utilized in patients using opioids? For which
type of chronic pain syndrome are CAM therapies likely to
be useful in patients using opioids? What are reasonable
outcomes to expect from CAM therapy and opioids?
Should patients be started on opioids before all appropri-
ate CAM therapies have been exhausted? With the increas-
ing use of opioids and CAM therapies for chronic pain
clinicians need evidence to try to answer these questions.
Naturalistic prospective cohort studies and randomized
control trials are needed to help physicians, health policy
makers and patients.
The study has a number of strengths including a large
sample size (n-908), high participation rates (78%), a
diverse population or rural and urban adults (25% minor-
ity), a large number of pain diagnosis, patients on chronic
opioid therapy, state of the art research procedures, exten-
sive information on potential confounders such as depres-
sion and substance abuse, and findings of interest to
clinicians. Limitations include the retrospective nature of
the data, limited information on CAM therapy reported
by each patient, and dependence on patient self report
questionnaires and interviews. In addition, due the small
number of subjects who used individual CAM therapies,
we were not able to assess which factors predict a subject's
positive response to these therapies.
While Table 2 provides preliminary data that suggests
many patients with severe chronic pain find CAM therapy
helpful, our ability to determine the efficacy of CAM ther-
apies was limited to self-report. We did not have the
resources to conduct an extensive interview with research
subjects. In addition, we used a single question to assess
patient self-reported efficacy, (i.e. was CAM therapy help-
ful (yes or no)?), which did not take multiple variables
into account, such as indications for treatment, duration
of treatment, provider variability, or dosage and quality of
herbs/supplements. We are addressing a wide range of
CAM therapies, each with great variability. Additionally,
many of the CAM therapies can potentially have added
effects on reducing pain and assisting patients to live more
normal lives.
Recommendations
Chronic opioid therapy has become a common treatment
method for severe chronic pain. Given the well-known
side-effects and risk profiles of chronic opiod therapy,
including addiction, aberrant drug behaviors, cognitive
Table 3: CAM use in chronic pain patients on opioids by patient characteristics; results from logistic regression analysis *. (The sample 
consists of 908 subjects receiving chronic opioid therapy)
Adjusted Odds Ratio ** 95% Confidence Interval p-value
Variables:
Age (per 10 years) ** 0.73 (0.63, 0.85) <.01
Female 2.27 (1.64, 3.14) <.01
Education (per 4 yrs) 1.41 (1.10, 1.82) <.01
Race:
White 1.00 ---
African American 0.82 (0.57, 1.18) .588
Other 0.45 (0.12, 1.75) .308
Pain Severity 1.11 (1.01, 1.22) .026
SF-36 physical component (per 10 points) 1.05 (0.95, 1.15) .340
SF-36 mental component (per 10 points) 0.93 (0.85, 1.01) .092
Total income (per $1000) 1.18 (1.06, 1.31) .05
Primary pain site:
Neck/upper back 2.27 (1.24, 4.14) .01
Multiple sites 1.81 (1.05, 3.11) .033
Headaches 1.42 (0.84, 2.40) .187
Lower back 1.00 (0.72, 1.39) .995
Others 1.00 ---
Cocaine tox screen negative 1.84 (1.01, 3.36) .047
* This table reports the adjusted odds ratio for each variable included in the analysis. The odds ratios in this table are adjusted for all variables listed 
in table 3, using a logistic regression analysis.
**For age we elected to use 10 years increments. As noted in the table the odds of using CAM interventions compared to not using CAM methods 
were reduced by a factor of 0.73 for every 10 year increment of increasing age. This finding suggests that after adjusting for all the factors in the 
model, young adults are more likely to use CAM therapy than older adults.Publish with BioMed Central    and   every 
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effects and respiratory depression, clinicians are typically
interested in the lowest effective dosing strategy. Our data
suggest that patients use and may benefit from specific
CAM therapies. Clinicians treating chronic pain patients
may consider use of these therapies as initial or adjunctive
treatment. Whether opioid use in chronic pain patients
can be reduced by introducing CAM therapies remains to
be studied, but is of interest especially if physicians are
considering utilizing opioid treatment for the remainder
of the patient's life.
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